Literature DB >> 29588805

Contemporary Techniques for Coronary Chronic Total Occlusions Revascularisation: Sharing Experience in a Global World: Proceedings of a satellite symposium held at EuroPCR on May 20th - 23rd 2014 in Paris Katrina Mountfort, Medical Writer, Radcliffe Cardiology.

Katrina Mountfort1,2,3,4,5,6,7, Heinz Joachim Büttner1, Masahisa Yamane2, Nicolaus Reifart3, Javier Escaned4, Georgios Sianos5, Omer Goktekin6, Roberto Garbo7.   

Abstract

Chronic total occlusions (CTO) are the most challenging lesions treated by interventional cardiologists. A symposium at EuroPCR 2014 discussed factors influencing the success of percutaneous intervention (PCI) in CTO. Current treatment paradigms suggest that one or two vessel disease should be treated by PCI while three-vessel disease requires surgery if complete revascularisation cannot be achieved with PCI. In patients with CTO and multi-vessel disease timing is key, and evidence of ischaemic burden and expected completeness of revascularisation is required before PCI is undertaken. Other factors affecting procedural success include the available equipment and expertise of the operator. Flexiblity in strategy selection is also important as it is frequently necessary to switch strategies during the procedure. The presentation included two live cases that illustrated the complexity of this procedure.

Entities:  

Keywords:  Coronary artery disease; chronic total occlusion; percutaneous intervention

Year:  2014        PMID: 29588805      PMCID: PMC5808596          DOI: 10.15420/icr.2014.9.3.213

Source DB:  PubMed          Journal:  Interv Cardiol        ISSN: 1756-1485


  10 in total

Review 1.  Effectiveness of recanalization of chronic total occlusions: a systematic review and meta-analysis.

Authors:  Dominique Joyal; Jonathan Afilalo; Stéphane Rinfret
Journal:  Am Heart J       Date:  2010-07       Impact factor: 4.749

Review 2.  Chronic total occlusions--a stiff challenge requiring a major breakthrough: is there light at the end of the tunnel?

Authors:  S Aziz; D R Ramsdale
Journal:  Heart       Date:  2005-06       Impact factor: 5.994

Review 3.  Recanalisation of chronic total coronary occlusions: 2012 consensus document from the EuroCTO club.

Authors:  Georgios Sianos; Gerald S Werner; Alfredo R Galassi; Michail I Papafaklis; Javier Escaned; David Hildick-Smith; Evald Høj Christiansen; Anthony Gershlick; Mauro Carlino; Angelos Karlas; Nikolaos V Konstantinidis; Salvatore D Tomasello; Carlo Di Mario; Nicolaus Reifart
Journal:  EuroIntervention       Date:  2012-05-15       Impact factor: 6.534

4.  Quantification of incomplete revascularization and its association with five-year mortality in the synergy between percutaneous coronary intervention with taxus and cardiac surgery (SYNTAX) trial validation of the residual SYNTAX score.

Authors:  Vasim Farooq; Patrick W Serruys; Christos V Bourantas; Yaojun Zhang; Takashi Muramatsu; Ted Feldman; David R Holmes; Michael Mack; Marie Claude Morice; Elisabeth Ståhle; Antonio Colombo; Ton de Vries; Marie-angèle Morel; Keith D Dawkins; Arie-Pieter Kappetein; Friedrich W Mohr
Journal:  Circulation       Date:  2013-06-13       Impact factor: 29.690

5.  Outcomes after complete versus incomplete revascularization of patients with multivessel coronary artery disease: a meta-analysis of 89,883 patients enrolled in randomized clinical trials and observational studies.

Authors:  Santiago Garcia; Yader Sandoval; Henri Roukoz; Selcuk Adabag; Mariana Canoniero; Demetris Yannopoulos; Emmanouil S Brilakis
Journal:  J Am Coll Cardiol       Date:  2013-06-07       Impact factor: 24.094

6.  Predicting successful guidewire crossing through chronic total occlusion of native coronary lesions within 30 minutes: the J-CTO (Multicenter CTO Registry in Japan) score as a difficulty grading and time assessment tool.

Authors:  Yoshihiro Morino; Mitsuru Abe; Takeshi Morimoto; Takeshi Kimura; Yasuhiko Hayashi; Toshiya Muramatsu; Masahiko Ochiai; Yuichi Noguchi; Kenichi Kato; Yoshisato Shibata; Yoshikazu Hiasa; Osamu Doi; Takehiro Yamashita; Tomoaki Hinohara; Hiroyuki Tanaka; Kazuaki Mitsudo
Journal:  JACC Cardiovasc Interv       Date:  2011-02       Impact factor: 11.195

7.  The negative impact of incomplete angiographic revascularization on clinical outcomes and its association with total occlusions: the SYNTAX (Synergy Between Percutaneous Coronary Intervention with Taxus and Cardiac Surgery) trial.

Authors:  Vasim Farooq; Patrick W Serruys; Hector M Garcia-Garcia; Yaojun Zhang; Christos V Bourantas; David R Holmes; Michael Mack; Ted Feldman; Marie-Claude Morice; Elisabeth Ståhle; Stefan James; Antonio Colombo; Roberto Diletti; Michail I Papafaklis; Ton de Vries; Marie-Angèle Morel; Gerrit Anne van Es; Friedrich W Mohr; Keith D Dawkins; Arie-Pieter Kappetein; Georgios Sianos; Eric Boersma
Journal:  J Am Coll Cardiol       Date:  2012-12-19       Impact factor: 24.094

8.  Prognostic impact of a chronic total occlusion in a non-infarct-related artery in patients with ST-segment elevation myocardial infarction: 3-year results from the HORIZONS-AMI trial.

Authors:  Bimmer E Claessen; George D Dangas; Giora Weisz; Bernhard Witzenbichler; Giulio Guagliumi; Martin Möckel; Sorin J Brener; Ke Xu; José P S Henriques; Roxana Mehran; Gregg W Stone
Journal:  Eur Heart J       Date:  2012-01-12       Impact factor: 29.983

9.  Changes in myocardial ischemic burden following percutaneous coronary intervention of chronic total occlusions.

Authors:  David M Safley; Sindhu Koshy; J Aaron Grantham; Kevin A Bybee; John A House; Kevin F Kennedy; Barry D Rutherford
Journal:  Catheter Cardiovasc Interv       Date:  2011-03-16       Impact factor: 2.692

10.  Percutaneous coronary intervention versus coronary-artery bypass grafting for severe coronary artery disease.

Authors:  Patrick W Serruys; Marie-Claude Morice; A Pieter Kappetein; Antonio Colombo; David R Holmes; Michael J Mack; Elisabeth Ståhle; Ted E Feldman; Marcel van den Brand; Eric J Bass; Nic Van Dyck; Katrin Leadley; Keith D Dawkins; Friedrich W Mohr
Journal:  N Engl J Med       Date:  2009-02-18       Impact factor: 91.245

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.